Stocks and InvestingStocks and Investing
Thu, December 21, 2023
Wed, December 20, 2023
Tue, December 19, 2023
Mon, December 18, 2023

Alex Thompson Maintained (TVTX) at Hold with Increased Target to $10 on, Dec 18th, 2023


Published on 2024-10-28 08:02:13 - WOPRAI, Alex Thompson
  Print publication without navigation


Alex Thompson of Stifel, Maintained "Travere Therapeutics, Inc." (TVTX) at Hold with Increased Target from $8 to $10 on, Dec 18th, 2023.

Alex has made no other calls on TVTX in the last 4 months.



There are 10 other peers that have a rating on TVTX. Out of the 10 peers that are also analyzing TVTX, 3 agree with Alex's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Nicole Gabreski of "Piper Sandler" Maintained at Hold with Decreased Target to $10 on, Wednesday, October 25th, 2023
  • Mohit Bansal of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $8 on, Friday, September 22nd, 2023
  • Tim Lugo of "William Blair" Downgraded from Buy to Hold on, Thursday, September 21st, 2023


These are the ratings of the 7 analyists that currently disagree with Alex


  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $20 on, Friday, December 15th, 2023
  • Carly Kenselaar of "Citigroup" Upgraded from Hold to Strong Buy and Increased Target to $10 on, Tuesday, December 5th, 2023
  • Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $12 on, Friday, September 29th, 2023
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Decreased Target to $14 on, Friday, September 22nd, 2023
  • Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $12 on, Friday, September 22nd, 2023
  • Greg Harrison of "B of A Securities" Maintained at Strong Buy with Decreased Target to $27 on, Friday, September 22nd, 2023
  • Vamil Divan of "Guggenheim" Maintained at Strong Buy with Decreased Target to $18 on, Friday, September 22nd, 2023